Clinical Trial Update: Levosimendan in Acute Kidney Injury Study [Phase 2, Phase 3]

View source ↗

Summary

Update on a Phase 2/Phase 3 study of levosimendan for acute kidney injury; current status of the trial is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kidney Injury

Drugs mentioned

• Levosimendan (levosimendan)

Snippet

Sponsor: VieCuri Medical Centre | Conditions: Acute Kidney Injury | Phase 2, Phase 3 | Status: UNKNOWN